An Evaluation of Activity Trackers for Monitoring Parkinson's Disease Patient Outcomes

If you need an accessible version of this item, please submit a remediation request.
Date
2016
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease in America. PD results in adverse outcomes including motor impairments and non-motor impairments such as cognition and sleep. Medication has a limited impact on treating PD and slowing down the progression of the disease. Anecdotal reports and some research show that intensive activity has been beneficial not only to slow down the progression of PD, but also may reverse the onset of more severe PD symptoms.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Source
Alternative Title
Type
Poster
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}